Automated Cell Counter Market Size - By Product Type (Fluorescence Image-based Cell Counter, Flow Cytometers, Coulter Counter), By Application (Blood Cells, Microbial Cells, Cell Lines), By End-use– Global Forecast, 2023 - 2032

Automated Cell Counter Market Size

Automated Cell Counter Market size was worth USD 6.3 billion in 2022 and is projected to record over 5.5% CAGR from 2023 to 2032 driven by the rising prevalence of infectious diseases worldwide.
 

The increasing adoption of unhealthy lifestyles and behaviors, such as alcohol drinking and cigarette smoking along with the subsequently growing incidence of chronic illnesses will drive the market development. According to the WHO, chronic illnesses resulted in more than 71% of all fatalities worldwide. The surging episodes of diabetes, cancer, chronic respiratory ailments, and cardiovascular illnesses have spurred the higher need for sophisticated diagnostic tools, such as automated cell counts.

The lack of skilled labor and the significantly impeding efforts to achieve health-related development goals throughout the world along with the slowing progress of universal health care may limit the market gains. It is estimated that there would be a shortage of 12.9 million healthcare workers worldwide by 2035. However, the continued government measures to provide professional skill-based education and training will assist in overcoming this industry constraint.
 

COVID-19 Impact

The COVID-19 pandemic had favorable influence on the demand for automated cell counter systems. This was mainly due to their rising application in clinical research investigations and accelerated usage in hospital and pharmaceutical settings during the initial stages of the pandemic. Furthermore, the increasing demand for plasma treatment and the significant increase in hospital admissions fueled the need for automated cell counters.
 

Automated Cell Counter Market Trends

Increasing R&D investments worldwide to cater to the higher need for efficient diagnostic solutions due to the surging burden of diseases is expected to boost the market prospects. The advent of serious infectious diseases, including COVID-19 and the Ebola epidemic has further increased the demand for research activities globally. It has been reported that the U.S. is one of the top nations for spending on R&D followed by China and Japan and spent more than USD 679 billion on domestic R&D projects in 2022.
 

Automated Cell Counter Market Analysis

Based on product, the automated cell counter industry from the fluorescence image-based cell counter segment is expected to record 5.3% CAGR from 2023 to 2032. The progression can be attributed to the rising number of people suffering from urinary tract infections (UTIs), kidney diseases, and diabetes. Fluorescence image-based cell counting devices provide valuable insights into cellular dynamics, biomarker expression, and disease progression. The growing demand for advanced cell analysis techniques in research, drug discovery, and clinical diagnostics.
 

Automated cell counter market share from the blood cell application segment is expected to reach USD 4.9 billion by 2032. Automated blood cell counting methods are more dependable and effective compared to traditional techniques. The growing adoption of newly developed technologies has increased the need to test the viability of blood cells and detect the kind of cells present in samples. Furthermore, the rising frequency of blood-related illnesses along with the growing need for rapid and dependable diagnostic solutions.
 

North America held over 37.9% of the automated cell counter market share in 2022 and is projected to reach USD 3.8 billion by 2032 driven by the robust presence of well-established healthcare infrastructure and research facilities. The rising prevalence of chronic diseases has spurred the growing need for early disease detection and monitoring, further fueling the demand for automated cell counters.
 

Automated Cell Counter Market Share

Some leading companies operating in the automated cell counter market include

• Olympus Corporation
• Thermo Fisher Scientific Inc
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Sysmex Corporation
• NanoEnTek
• F. Hoffmann-La Roche Ltd
• Danaher (Beckman Coulter Inc. and Radiometer)
• Agilent Technologies, Inc.
   

Automated Cell Counter Market News

• In June 2022, Sysmex Corporation announced the FAD approval for its XN-10 hematology analyzer with blood bank mode. XN-10 is a technologically sophisticated automated hematology analyzer deployed for counting white blood cells.
   

Automated cell counter market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product Type (USD Million & Units)

• Fluorescence image-based cell counter
• Flow cytometer
• Coulter counter

By Application USD Million)

• Blood cells
• Cell lines
• Microbial cells
• Others

By End-use (USD Million)

• Pharmaceutical & biotechnology companies
• Hospitals
• Diagnostic laboratories
• Research institutes
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Poland
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Turkey